Autosomal Dominant Polycystic Kidney Disease clinical trials at UCSF
2 in progress, 1 open to eligible people
Showing trials for
VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
open to eligible people ages 18-65
The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharmacokinetics (PK) of VX-407.
San Francisco, California and other locations
Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
Sorry, in progress, not accepting new patients
The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene variant groups in the ADPKD population.
San Francisco, California and other locations
Last updated: